NCT02113982 2024-08-01
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
Stemline Therapeutics, Inc.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT04317781 2024-07-31
Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00397579 2019-04-23
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT02420873 2018-08-28
An Open-label Phase II Study of Lorvotuzumab Mertansine
M.D. Anderson Cancer Center
Phase 2 Completed